Neurocrine Biosciences (NBIX) Enterprise Value (2010 - 2026)
Neurocrine Biosciences' Enterprise Value came in at $16.73 billion for Q2 2026, up 45.9% from $11.47 billion a year earlier and up 40.2% from the prior quarter.
Powered by 
Analysis
Neurocrine Biosciences (NBIX) Enterprise Value (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Neurocrine Biosciences reported Enterprise Value of $12.82 billion, up 56.0% year-over-year; for FY2025, it came in at $12.72 billion, up 1.8% from FY2024.
- Enterprise Value has increased in each of the last four years, with a five-year compound annual growth rate of 9.3% (FY2020 to FY2025).
- Going back by year, Enterprise Value was $12.49 billion in FY2024 (+4.4%), $11.97 billion in FY2023 (+13.6%), $10.53 billion in FY2022 (+42.9%) and $7.37 billion in FY2021 (-9.7%).
- The Q2 2026 figure represents the highest quarterly Enterprise Value in data going back to Q2 2010.
- Year-over-year, Enterprise Value has increased for four consecutive quarters, with growth averaging 8.5% over the last eight quarters.
- The fastest year-over-year change in Enterprise Value over five years came in Q2 2024 (growth of 56.2%), and the weakest in Q1 2025 (a decline of 21.0%).
- Business Quant data shows NBIX's Enterprise Value at $11.94 billion (Q1 2026), $12.72 billion (Q4 2025) and $12.88 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Neurocrine Biosciences | 14.29 Bn | 9.99 Bn | 935.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16.73 Bn |
| Mar 31, 2026 | 11.94 Bn |
| Dec 31, 2025 | 12.72 Bn |
| Sep 30, 2025 | 12.88 Bn |
| Jun 30, 2025 | 11.47 Bn |
| Mar 31, 2025 | 10.01 Bn |
| Dec 31, 2024 | 12.49 Bn |
| Sep 30, 2024 | 10.43 Bn |
| Jun 30, 2024 | 12.85 Bn |
| Mar 31, 2024 | 12.66 Bn |
| Dec 31, 2023 | 11.97 Bn |
| Sep 30, 2023 | 9.95 Bn |
| Jun 30, 2023 | 8.23 Bn |
| Mar 31, 2023 | 8.97 Bn |
| Dec 31, 2022 | 10.53 Bn |
| Sep 30, 2022 | 9.41 Bn |
| Jun 30, 2022 | 8.67 Bn |
| Mar 31, 2022 | 8.29 Bn |
| Dec 31, 2021 | 7.37 Bn |
| Sep 30, 2021 | 8.33 Bn |
API Access
Neurocrine Biosciences Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=NBIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "NBIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=NBIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();